( September 18, 2025, 10:31 AM EDT) -- WILMINGTON, Del. — A pharmaceutical company that sought “equitable relief that is unprecedented under” federal law “has not established that its story warrants such relief,” a Delaware federal judge said, denying a motion that sought to bar a competitor from seeking approval from the U.S. Food and Drug Administration for a drug to treat narcolepsy....